Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |